ASX 200 set to fall – APT, Z1P & WOW shares in focus
Drew Meredith, CFP
June 21, 2021
The S&P/ASX 200 (ASX: XJO) finished 0.1% higher on Friday
CSL Limited (ASX: CSL) is Australia’s largest (and some might say best) healthcare company, specialising in biopharmaceuticals. Founded in the late 1900s as the Commonwealth Serum Laboratories, CSL was sold by the Australian Government to Australian investors via the share market in 1994 at $2.30 per share, at which time it doubled its size through an international acquisition. CSL is a global leader in blood plasma vaccines (think: the flu) and antivenoms, providing relief for potentially life-threatening medical conditions.
The S&P/ASX 200 (ASX: XJO) finished 0.1% higher on Friday
The US Federal Reserve has indicated that interest rate rises
The S&P/ASX 200 (INDEXASX:XJO) is set to open lower on
The S&P/ASX 200 (INDEXASX:XJO) finished Friday on a positive note.
There are a number of reasons to consider looking at
The S&P/ASX 200 (INDEXASX:XJO) followed Wall Street lower on Thursday.
The S&P/ASX 200 (INDEXASX:XJO) reached a 14-month high on Wednesday.
The Mayne Pharma Group Ltd (ASX: MYX) share price soared
BetaShares Australia 200 ETF (ASX: A200) might be one of
Want to level-up your analytical skills and investing insights but don’t know where to start? Join 50,000 Australian investors on our mailing list and we’ll send you our favourite podcasts, courses, resources and investment articles every Sunday morning. Grab a coffee and let Owen and the team bring you the best insights.
